Evidence map›Paper›PMID 21930925›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2011

Squalamine as a broad-spectrum systemic antiviral agent with therapeutic potential.

Michael Zasloff, A Paige Adams, Bernard Beckerman, Ann Campbell, Ziying Han, Erik Luijten, Isaura Meza, Justin Julander, Abhijit Mishra, Wei Qu and 3 more

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 106 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Studying the trafficking of labeled trodusquemine and its application as nerve marker for light-sheet and expansion microscopy.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2022
    Article
  7. Review
  8. Article
  9. Review
  10. The anti-hepatitis B virus and anti-hepatotoxic efficacies of solanopubamine, a rare alkaloid fromSaudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2022
    Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Comparative Studies in the A30P and A53T α-SynucleinFrontiers in cell and developmental biology · 2021
    Article
  16. Article
  17. Drugs for the Treatment of Zika Virus Infection.Journal of medicinal chemistry · 2020
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 9 institutions in 3 countries.

Michael ZasloffTransplant Institute, Department of Surgery, Georgetown University Medical Center, Washington, DC 20007, USA.
A Paige Adams
Bernard Beckerman
Ann Campbell
Ziying Han
Erik Luijten
Isaura Meza
Justin Julander
Abhijit Mishra
Wei Qu
John M Taylor
Scott C Weaver
Gerard C L Wong
Northwestern University · USEastern Virginia Medical School · USThe University of Texas Medical Branch at Galveston · USCalifornia NanoSystems Institute · USFox Chase Cancer Center · USGeorgetown University · USInstituto Politécnico Nacional · MXUniversity of California, Los Angeles · USUtah State University · US

Funding

WRCE Nonhuman Primate CoreU54AI057156 · NIAID · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI WALKER, DAVID H · 2003 to 2013
$102.6M
Antimicrobial Oligomers for BioDefense and Emerging Food Borne Infectious DiseaseU01AI082192 · NIAID · UNIVERSITY OF MASSACHUSETTS AMHERST · PI TEW, GREGORY N. · 2009 to 2013
$7.0M
Pathogenesis of Subtype IE Venezuelan Equine Encephalitis VirusK08AI077796 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI ADAMS, ALISON PAIGE · 2010 to 2012
$359k
NIAID NIH HHS 1U01-AI082192-01NIAID NIH HHS K08 AI077796NIAID NIH HHS U01 AI082192NIAID NIH HHS U54 AI057156PHS HHS U54 AIO57156
6 · The paper itself

Abstract

Antiviral compounds that increase the resistance of host tissues represent an attractive class of therapeutic. Here, we show that squalamine, a compound previously isolated from the tissues of the dogfish shark (Squalus acanthias) and the sea lamprey (Petromyzon marinus), exhibits broad-spectrum antiviral activity against human pathogens, which were studied in vitro as well as in vivo. Both RNA- and DNA-enveloped viruses are shown to be susceptible. The proposed mechanism involves the capacity of squalamine, a cationic amphipathic sterol, to neutralize the negative electrostatic surface charge of intracellular membranes in a way that renders the cell less effective in supporting viral replication. Because squalamine can be readily synthesized and has a known safety profile in man, we believe its potential as a broad-spectrum human antiviral agent should be explored.

Indexed as

AnimalsAnti-Bacterial AgentsAntiviral AgentsCell LineCell MembraneCells, CulturedCholestanolsCricetinaeFemaleHepatitis B virusHepatitis Delta VirusHepatocytesHumansMaleMesocricetusMiceAnti-Bacterial AgentsAntiviral AgentsCholestanolsrac1 GTP-Binding Proteinsqualamine

Identifiers

PMID21930925
PMCPMC3179074
OpenAlexW2021189636

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.